• Log In
  • Register
  • Contact
  • Membership Smart Home Sector

    The Smart Home market is reaching an inflection point. Service providers, including telcos, cable operators, and home security companies, as well as retailers and device OEMs alike are bringing a range of new hardware, services, and offers to market. Adding opportunity and complexity is the intersection of smart home services and ecosystems with wearables, new sensor technologies, big data and analytics, and health management services. Consumer IT heavyweights and startups alike are driving adoption with a growing range of simple to install connected device, pushing smart home services into more and more homes and forcing long standing specialists to adapt in order to compete. Surviving in the new competitive environment means staying hyperaware of a range of vectors – the latest consumer product and service trends, emerging connectivity options, product mixes, service delivery and platform approaches, and eco-system partner developments.

    This sector tracks these ongoing developments to provide deep-dive supplier assessments across smart home connectivity, devices, platforms, and services. Market data is provided for shipments, installations, and revenues for smart home systems, devices, controllers, consumer appliances, and service provider verticals. This sector is particularly relevant to those who are looking to embrace the opportunity of new service markets and extended customer relationships born from advances in wireless applications and networking technologies. The smart home is a key proving ground for the consumer IoE.

    Clear Filter

    ABI Insight

    Medtronic Continues to Close Loop on Development of an Artificial Pancreas

    3Q 2016

    On September 28, 2016, Medtronic announced that it received approval from the U.S. Food and Drug Administration of its MiniMed 670G system, which is billed as the first hybrid closed-loop insulin delivery system. Medtronic had filed for premarket approval (PMA) of the system earlier this year, and an approval was not expected until early 2017 at the earliest. The speed with which the FDA granted approval is a result of the success of the system’s trial and the need for more efficient diabetes management systems. The device will be available for commercial use in spring 2017. At the American Diabetes Association’s Scientific Sessions in June 2016, Medtronic presented data from the six month trial of its MiniMed 670G diabetes management system. There were 124 patients who participated in the study. They used the device, which wirelessly connects an insulin pump and glucose monitor to automatically track and adjust blood glucose levels. The device is not a true closed-loop system because it still requires daily manual calibration and user input, but it is nonetheless a significant step in the development of a true closed-loop system—an artificial pancreas.



    Sam Rosen

    Managing Director and VP, Video, OTT and AR/VR

    Jonathan Collins

    Research Director

    Michael Inouye

    Principal Analyst

    Ryan Martin

    Senior Analyst

    Khin Sandi Lynn

    Industry Analyst

    Shelli Bernard

    Research Analyst

    Stephanie Lawrence

    Research Analyst